1) Interleukin-1 receptor antagonist
白介素1受体拮抗剂
1.
Methods: The levels of interleukin-1 β(IL-1 β),interleukin-1 receptor antagonist(IL-1ra) and tumor necrosis factor-α(TNF-α) in the cerebrospinal fluid(CSF) were determined by ELISA in 45 patients with AD,30 patients with vascular dementia(VD) and 25 normal subjects.
方法:用夹心式酶联免疫吸附法测定轻、中、重度AD患者,血管性痴呆(VD)患者与正常老年人脑脊液中白介素-1β(IL-1β)、肿瘤坏死因子α(TNFα)和白介素1受体拮抗剂(IL-1ra)的水平。
2.
Methods ELISA was used to measure the levels of interleukin-1 β (IL-1 β), interleukin-1 receptor antagonist (IL-1ra) and tumor necrosis factor α (TNF-α) in the cerebrospinal fluid (CSF) of 45 patients with AD in different clinical stages, 30 (patients) with vascular dementia (VD) and 25 normal controls.
方法用夹心式酶联免疫吸附法测定轻、中、重度AD患者、血管性痴呆(VD)患者与正常老年人脑脊液中白介素1β(IL1β)、肿瘤坏死因子α(TNFα)和白介素1受体拮抗剂(IL1ra)的水平;以蛋白印记法及激酶活性测定法检测半胱天冬氨酸蛋白酶3(caspase3)的表达和活性。
2) IL-1 receptor antagonist
白介素1受体拮抗剂
1.
Objective To study the effects of the IL-1 receptor antagonist (IL-1Ra) on matrix metalloproteinase 1 (MMP-1) expression in UV-irradiated fibroblasts.
目的探讨白介素1受体拮抗剂(IL—1Ra)对紫外线(UV)辐射的成纤维细胞分泌基质金属蛋白酶1(MMP-1)的影响。
3) hIL-1Ra
人白介素-1受体拮抗剂
1.
Objective To examine the gene expression of human Interleukin 1 Receptor Antagonist gene (hIL-1Ra) after gene transferation in temporomandibular joint (TMJ) osteoarthritis.
目的研究人白介素-1受体拮抗剂(hIL-1Ra)基因转染兔颞下颌关节骨关节病(TMJOA)动物模型后,颞下颌关节腔内hIL-1Ra蛋白的表达和定位。
4) Interleukin-1 receptor antagonist
白介素-1受体拮抗剂
1.
objective: An interleukin-1 receptor antagonist blocking the function of Interleukin-1 was used to investigate the role of Interleukin-1 and its receptor antagonist in skeletal muscle ischemia-reperfusion injury(SMRI).
目的 应用白介素-1受体拮抗剂阻断白介素-1的功能以探讨白介素-1及其受体拮抗剂在骨骼肌缺血再灌注损伤中的作用。
5) IL-1RN
白介素-1受体拮抗因子
1.
Objective To evaluate the relationship of the polymorphism of interleukin-1 receptor antagonist(IL-1RN) gene and patients with ankylosing spondylitis(AS).
目的:研究白介素-1受体拮抗因子(IL-1RN)基因多态性与强直性脊柱炎(ankylosing spondylitis,AS)的相关性。
6) interleukin-1 receptor antagonist
白细胞介素-1受体拮抗剂
1.
The effects of the interleukin-1 receptor antagonist protein on the degenerative intervertebral disc of the bipedal rat;
白细胞介素-1受体拮抗剂对大鼠退变椎间盘治疗作用的研究
2.
Investigation of the serum interleukin-1 receptor antagonist, interleuleukin-1β and high-sensitivity C-reactive protein levels in type 2 diabetic patients with nephropathy;
2型糖尿病肾病患者血清白细胞介素-1受体拮抗剂、白细胞介素-1β和超敏C反应蛋白的检测研究
3.
Purification of recombinant human interleukin-1 receptor antagonist and analysis of its two different oxidative forms;
人重组白细胞介素-1受体拮抗剂高效纯化及不同氧化态转换
补充资料：血管紧张素II拮抗剂
分子式：
分子量：
CAS号：
性质：为能选择性地抗血管紧张素Ⅱ生物活性的药物。其中如肌内抗增压素（saralasin)是8肽化合物，与血管紧张素Ⅱ 呈特异性对抗效应，能使血压明显降低，对伴有肾素水平升高的高血压有效。
分子量：
CAS号：
性质：为能选择性地抗血管紧张素Ⅱ生物活性的药物。其中如肌内抗增压素（saralasin)是8肽化合物，与血管紧张素Ⅱ 呈特异性对抗效应，能使血压明显降低，对伴有肾素水平升高的高血压有效。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条